Page 55 - Read Online
P. 55

Page 4 of 10           Dengsoe et al. Plast Aesthet Res 2024;11:25  https://dx.doi.org/10.20517/2347-9264.2024.20

               RESULTS
               Our search identified a total of 1,077 publications. 187 duplicates were removed, some manually and some
               automatically by Covidence. That left a total of 890 publications for title and abstract screening. In this
               process, 757 publications were excluded, leaving a total of 133 publications for full text screening. Full text
               screening led to the exclusion of 126 publications due to criteria which are specified in a PRISMA flow chart
               [Supplementary Figure 1]. It is worth mentioning that a total of 20 articles had to be excluded because it was
               not possible, even by a medical librarian, to access the full text version of the article or that the only version
               published online was a conference abstract. Three articles were excluded because they involved only
               implant-based reconstructions and 21 were excluded because they only involved reconstructions based on
               pedicled flaps or did not specify how many patients received a free flap reconstruction. Four articles did
               specify the proportion of patients with free flap reconstructions, but they did not distinguish between
               pedicled or free flap reconstructions when evaluating complications or time from surgery to initiation of
               adjuvant therapy. When screening was completed, seven articles were included in the systematic
               review [15,16,22-26] . The study characteristics are presented in  Supplementary Table 2. Six studies are
               retrospective case-control studies and compare one group of patients receiving mastectomy immediately
               followed by a free flap reconstruction (cases) to another group of patients receiving only a mastectomy
               (controls). One study by Nguyen et al. is a retrospective cross-sectional study that sorely investigates 30
               patients receiving DIEP reconstructions without comparing to a control group . A total of 267 patients
                                                                                    [26]
               treated with mastectomy followed by immediate free flap reconstruction and 2,622 patients treated with
               mastectomy-only were included in this systematic review. Most reconstructions were performed using a
               DIEP flap, but free TRAM-flaps, S/I-GAP-flaps, SIEA-flaps, TUG-flaps and TMG-flaps were also used in
               some cases.

               Complications
               Only four studies included data on postoperative complications, specifically on free flap reconstruction.
               These data are presented in Supplementary Table 3. Lee et al. evaluated wound complications including
                                                                                 [23]
               wound dehiscence, infection, skin necrosis, seroma, and skin flap maceration . They found that 22% with
               DIEP-flap reconstructions and 2.5% with mastectomy-only had a wound complication. O’Connell et al.
               differentiated between any complication and major complications requiring further surgery or hospital
               readmission . They found that free flap reconstruction was strongly associated with major complications.
                         [24]

               Kontos et al. did not compare complication rates in the two groups . Instead, they evaluated the group of
                                                                        [16]
               patients who had a free flap reconstruction and where chemotherapy was initiated later than six weeks after
               surgery, trying to explain the reason for the delay. Most notably, six patients had complete or partial flap
               necrosis and three patients experienced abdominal wound dehiscence. Nguyen et al. divided complications
                                                                                 [26]
               into three categories based on their location: breast, donor site, and systemic . Four patients had further
               surgery due to either venous congestion or total flap loss. Two patients suffered abdominal wound
               dehiscence. Lastly, two patients had a pulmonary embolism and one patient developed pneumonia.

               Time to adjuvant therapy
               Six of the studies investigated solely adjuvant treatment with chemotherapy. Only one study by O’Connell et
               al. investigated adjuvant radiotherapy as well, specifying that 55% of patients - regardless of reconstruction
               or not - received chemotherapy as the first adjuvant treatment whereas 46% received radiotherapy as the
                                    [24]
               first adjuvant treatment . Five of the included studies calculated the mean time in days to initiation of
               adjuvant treatment, whereas two studies recorded time to adjuvant treatment as a categorial variable,
               describing the proportion of patients who had initiated treatment at a defined point in time. In one
                    [25]
               study , it was six weeks after surgery, and in another study , it was eight weeks after surgery. These data
                                                                  [22]
               are presented in supplementary table 4. In the study by Wilson et al., the median time to initiation of
   50   51   52   53   54   55   56   57   58   59   60